Reaction

Cystitis Haemorrhagic reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,967 reports · 140 co-occurring drugs

As of the last recalculation, Cystitis Haemorrhagic appears in 3,967 FAERS reports alongside 140 co-occurring drug terms. The strongest observed disproportionality signal is BUSULFAN (PRR 163.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Busulfan	436	163.2	167.9
Ganciclovir	200	107.9	110.1
Ganciclovir Sodium	203	106.0	108.1
Fludarabine Phosphate	656	104.7	106.4
Mesna Injection	147	96.9	98.6
Mesna	149	96.4	98.2
Anti-Thymocyte Globulin (Rabbit)	142	95.7	97.5
Thiotepa	136	77.3	78.4
Cyclophosphamide Injection, Solution	1,125	46.1	46.4
Cyclophosphamide	1,125	46.1	46.4
Cyclophosphamide For Injection	1,125	46.1	46.4
Valganciclovir Hydrochloride Powder,	101	44.6	44.9
Valganciclovir	128	36.8	37.0
Valganciclovir Hydrochloride	128	36.8	37.0
Melphalan Hydrochloride	164	35.8	36.0
Melphalan	146	34.9	35.1
Cyclosporine	583	32.1	32.2
Mycophenolate Mofetil	675	31.2	31.4
Mycophenolate Mofetil Hydrochloride	675	31.2	31.3
Ifosfamide	116	29.2	29.3
Micafungin Sodium	42	26.3	26.4
Etoposide	291	22.3	22.4
Tacrolimus Ointment 0.1%	453	21.4	21.5
Tacrolimus Extended-Release Capsules	453	21.4	21.4
Cytarabine	229	21.2	21.2
Basiliximab	46	20.8	20.8
Tacrolimus	525	20.1	20.2
Gefitinib	34	19.9	20.0
Alemtuzumab	69	19.0	19.1
Mycophenilic Acid	71	18.3	18.3
Filgrastim	122	17.5	17.6
Itraconazole	37	16.8	16.8
Aprepitant	57	16.4	16.5
Granisetron Hydrochloride	31	15.7	15.7
Amphotericin B	37	15.6	15.7
Posaconazole	47	15.3	15.4
Sirolimus	37	14.5	14.6
Posaconazole Delayed-Release	29	13.9	14.0
Voriconazole	78	13.7	13.8
Methylprednisolone	323	13.3	13.3
Doxorubicin	212	13.1	13.2
Voriconazole Injection	53	13.0	13.0
Mycophenolic Acid	77	12.9	12.9
Doxorubicin Hydrochloride	75	12.3	12.3
Polatuzumab Vedotin	20	10.8	10.8
Tranexamic Acid	18	10.7	10.7
Blinatumomab	21	10.6	10.6
Granisetron	21	10.6	10.6
Fluconazole	136	10.5	10.5
Pertuzumab	52	10.2	10.2
Vincristine Sulfate	55	10.0	10.0
Ursodiol	40	9.7	9.7
Ursosiol	32	8.7	8.7
Methotrexate	602	8.7	8.7
Meropenem	52	8.6	8.6
Cisplatin	123	8.5	8.5
Rituximab	312	8.3	8.3
Methotrexate Sodium	639	8.0	8.0
Axicabtagene Ciloleucel	15	8.0	8.0
Acyclovir	166	7.9	7.9
Cefepime Hydrochloride	24	7.9	7.9
Azacitidine	44	7.9	7.9
Hydrocortisone Sodium Succinate	14	7.8	7.8
Methylprednisolone Sodium Succinate	65	7.5	7.5
Pegaspargase	17	7.3	7.3
Dexamethasone Sodium Phosphate	14	7.3	7.3
Azacitidine For	25	7.3	7.3
Budesonide	78	7.1	7.1
Imatinib	23	6.9	6.9
Bendamustine Hcl	20	6.8	6.8
Thalidomide	47	6.8	6.8
Prednisolone	209	6.4	6.4
Prednisolone Oral	209	6.4	6.4
Prednisolone Oral Solution	209	6.4	6.4
Ruxolitinib	83	6.2	6.2
Bortezomib	102	6.1	6.1
Carboplatin	142	6.0	6.1
Anakinra	19	6.0	6.0
Piperacillin Sodium And Tazobactam Sodium	22	5.9	5.9
Cefepime	16	5.9	5.9
Docetaxel Anhydrous	74	5.9	5.9
Docetaxel	74	5.9	5.9
Trastuzumab	75	5.8	5.8
Fosaprepitant Dimeglumine	15	5.7	5.7
Bendamustine Hydrochloride	13	5.7	5.7
Daratumumab	43	5.7	5.7
Febuxostat Tablets 40 Mg	11	5.7	5.7
Febuxostat Tablets 80 Mg	11	5.7	5.7
Everolimus Tablets	18	5.7	5.7
Sulfamethoxazole And Trimethoprim	81	5.1	5.1
Dalteparin Sodium	10	5.0	5.0
Magnesium Oxide	39	4.9	4.9
Vancomycin Hydrochloride	61	4.9	4.9
Vancomycin	53	4.9	4.9
Levofloxacin	52	4.6	4.6
Levofloxacin In 5% Dextrose	52	4.6	4.6
Atovaquone	7	4.6	4.6
Gemcitabine	34	4.6	4.6
Paclitaxel (Aibumin-Bound)	70	4.5	4.5
Paclitaxel	82	4.4	4.4
Ciprofolxacin	58	4.3	4.3
Ciprofloxacin Tablets	58	4.3	4.3
Ketoconazole Foam	12	4.3	4.3
Ketoconazole Cream, 2%	12	4.3	4.3
Mercaptopurine	14	4.2	4.2
Dexamethasone 1.5 Mg	226	4.2	4.2
Dexamethasone	226	4.2	4.2
Piperacillin Sodium,Tazobactam Sodium	21	4.2	4.2
Piperacillin And Tazobactam	10	4.1	4.1
Prednisolone Acetate	8	4.1	4.1
Oseltamivir	6	4.0	4.0
Cladribine	7	3.8	3.8
Gemcitabine Hydrochloride	38	3.8	3.8
Phenytoin	15	3.8	3.8
Fam-Trastuzumab Deruxtecan-Nxki	7	3.6	3.7
Ketoconazole	12	3.6	3.6
Febuxostat	11	3.5	3.5
Dasatinib	23	3.3	3.3
Hydroxyurea	13	3.2	3.2
Bevacizumab	73	3.1	3.1
Valacyclovir	24	3.0	3.0
Rivaroxaban	111	2.8	2.9
Dapagliflozin	17	2.8	2.8
Amikacin	9	2.8	2.8
Capecitabine	45	2.6	2.6
Fondaparinux Sodium	4	2.6	2.6
Everolimus	25	2.6	2.6
Brentuximab Vedotin	5	2.6	2.6
Ibrutinib	39	2.5	2.5
Bleomycin Sulfate	5	2.5	2.5
Sorafenib	10	2.5	2.5
Ado-Trastuzumab Emtansine	4	2.5	2.5
Venetoclax	28	2.4	2.4
Pegfilgrastim	44	2.4	2.4
Romiplostim	6	2.1	2.1
Crizotinib	5	2.1	2.1
Irinotecan Hydrochloride	5	2.0	2.0
Panitumumab	6	2.0	2.0
Temozolomide	8	2.0	2.0
Atezolizumab	14	1.9	1.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.